LRQA Notified Body Lloyd’s Register Quality Assurance (LRQA) announced on June 13, 2019, that it will be withdrawing services relating to the Medical Devices Directive (93/42/EEC) (MDD) and the In-Vitro Diagnostic Devices Directive (98/79/EC) (IVDD) as well as its application to become a Netherlands-based EU Notified Body for the new…
The potential threat from a no-deal Brexit and the ongoing general Brexit chaos continues to have a negative impact upon the pharmaceutical industry. The UK was legally due to leave the EU on 12 April 2019 but of course the date for departure was delayed once again to 31 October…
Dutch relocation As previously reported here, at the end of March 2019, the European Medicines Agency (EMA) officially relocated from London to Amsterdam. EMA first moved to a temporary address at the Spark building in the north of Amsterdam while waiting for the completion of its purpose built new premises…
Update: In March 2019, we posted on the “MHRA’s extensive no-deal guidance updates for pharma and medtech”. Following on from the MHRA’s published guidance on ‘grandfathering’ and managing the lifecycle changes of medicinal products (see here), the MHRA has released an update in regards to the time period companies must…